文献速递皮肤肿瘤

肿瘤厚度下降趋势对意大利2010年代皮肤恶性黑色素瘤净生存率上升的相对贡献:一项基于人群的研究

The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population-based investigation.
PubMed 文献 · Br J Dermatol · 2022-05-31

基于意大利11个肿瘤登记处2003-2017年原发性皮肤恶性黑色素瘤数据,计算年龄标化5年净生存率及相对超额死亡风险(RER)。男性5年净生存率从2003-2007年86.8%升至2013-2017年93.2%,肿瘤厚度下降仅解释不足20%的生存改善。

要点

  • 男性患者5年净生存率从2003-2007年86.8%升至2013-2017年93.2%。
  • 肿瘤厚度下降对男性生存改善的贡献不足20%。
  • 2013年引入的靶向治疗和免疫检查点抑制剂可能解释剩余改善。

核心结论

  • 尤其对于男性患者,肿瘤厚度下降仅解释2013-2017年生存改善的一小部分。

研究设计与样本

  • 基于意大利11个肿瘤登记处2003-2017年登记的原发性皮肤恶性黑色素瘤患者,覆盖人口8 056 608(占2010年意大利人口13.4%),计算年龄标化5年净生存率,并用多因素分析计算相对超额死亡风险(RER)。

主要发现

  • 男性患者肿瘤厚度中位数2003-2007年为0.90 mm、2008-2012年为0.85 mm、2013-2017年为0.75 mm;女性患者分别为0.78 mm、0.77 mm、0.68 mm。
  • 男性患者5年净生存率2003-2007年为86.8%、2008-2012年为89.2%、2013-2017年为93.2%;女性患者分别为91.4%、92.0%、93.4%。
  • 2013-2017年男性患者尽管病变更厚,生存率与女性患者相同。
  • 男性患者将厚度纳入前向逐步模型后,2013-2017年 vs 2003-2007年的RER从0.64(95%CI 0.51-0.80)增至0.70(95%CI 0.57-0.86),表明厚度趋势解释不足20%的生存改善。
  • 女性患者结果不显著,但对缺失厚度值进行多重插补后,2013-2017年RER从0.74(95%CI 0.58-0.93)升至0.82(95%CI 0.66-1.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The long-term increase in survival from cutaneous malignant melanoma (CMM) is generally attributed to the decreasing trend in tumour thickness, the single most important prognostic factor. OBJECTIVES: To determine the relative contribution of decreased tumour thickness to the favourable trend in survival from CMM in Italy. METHODS: Eleven local cancer registries covering a population of 8 056 608 (13.4% of the Italian population in 2010) provided records for people with primary CMM registered between 2003 and 2017. Age-standardized 5-year net survival was calculated. Multivariate analysis of 5-year net survival was undertaken by calculating the relative excess risk (RER) of death. The relative contribution of the decrease in tumour thickness to the RER of death was evaluated using a forward stepwise flexible parametric survival model including the available prognostic factors. RESULTS: Over the study period, tumour thickness was inversely associated with 5-year net survival and multivariate RER in both sexes. The median thickness was 0.90 mm in 2003-2007, 0.85 mm in 2008-2012 and 0.75 mm in 2013-2017 among male patients, and 0.78 mm, 0.77 mm and 0.68 mm among female patients, respectively. The 5-year net survival was 86.8%, 89.2% and 93.2% in male patients, and 91.4%, 92.0% and 93.4% in female patients, respectively. In 2013-2017, male patients exhibited the same survival as female patients despite having thicker lesions. For them, the increasing survival trend was more pronounced with increasing thickness, and the inclusion of thickness in the forward stepwise model made the RER in 2013-2017 vs. 2003-2007 increase from 0.64 [95% confidence interval (CI) 0.51-0.80] to 0.70 (95% CI 0.57-0.86). This indicates that the thickness trend accounted for less than 20% of the survival increase. For female patients, the results were not significant but, with multiple imputation of missing thickness values, the RER rose from 0.74 (95% CI 0.58-0.93) to 0.82 (95% CI 0.66-1.02) in 2013-2017. CONCLUSIONS: For male patients in particular, decrease in tumour thickness accounted for a small part of the improvement in survival observed in 2013-2017. The introduction of targeted therapies and immune checkpoint inhibitors in 2013 is most likely to account for the remaining improvement.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Zamagni F, Bucchi L, Mancini S, et al. The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population-based investigation. Br J Dermatol. 2022. PMID: 35253204. doi:10.1111/bjd.21051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。